financetom
Business
financetom
/
Business
/
Dorman Products Insider Sold Shares Worth $3,393,287, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dorman Products Insider Sold Shares Worth $3,393,287, According to a Recent SEC Filing
Jan 28, 2025 2:53 PM

05:36 PM EST, 01/28/2025 (MT Newswires) -- Steven L Berman, Director, on January 24, 2025, sold 25,651 shares in Dorman Products ( DORM ) for $3,393,287. Following the Form 4 filing with the SEC, Berman has control over a total of 913,457 shares of the company, with 788,688 shares held directly and 124,769 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/868780/000162828025002852/xslF345X05/wk-form4_1738103615.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
OceanaGold Applies for Fast-track Approval of Waihi North Project in New Zealand
OceanaGold Applies for Fast-track Approval of Waihi North Project in New Zealand
Mar 4, 2025
07:58 AM EST, 03/04/2025 (MT Newswires) -- OceanaGold ( OCANF ) on Tuesday said it applied for fast-track approval of its Waihi North project in New Zealand. OceanaGold ( OCANF ) submitted the application under New Zealand's Fast-track Approvals Act 2024, and the company expects the project to be fully permitted under the law by the end of the year....
Wave Life Sciences Swings to Q4 Earnings, Revenue Rises
Wave Life Sciences Swings to Q4 Earnings, Revenue Rises
Mar 4, 2025
07:52 AM EST, 03/04/2025 (MT Newswires) -- Wave Life Sciences ( WVE ) reported Q4 net income Tuesday of $0.17 per diluted share, swinging from a loss of $0.15 a year earlier. Two analysts surveyed by FactSet expected a loss of $0.19. Revenue for the quarter ended Dec. 31 was $83.7 million, up from $29.1 million a year earlier. Analysts...
Natera Granted US Patent for Testing Single Nucleotide Variants
Natera Granted US Patent for Testing Single Nucleotide Variants
Mar 4, 2025
07:56 AM EST, 03/04/2025 (MT Newswires) -- Natera ( NTRA ) said Tuesday that the US Patent and Trademark Office has issued the company a patent for testing single nucleotide variants in circulating-tumor DNA. The company said the patent relates to certain methods of preparation for tumor-informed ctDNA monitoring using whole exome or whole genome sequencing and describes various modes...
Market Chatter: Seven & i Founding Family Says Buyout Proposal Scrapped; Denies Couche-Tard Rejection
Market Chatter: Seven & i Founding Family Says Buyout Proposal Scrapped; Denies Couche-Tard Rejection
Mar 4, 2025
07:51 AM EST, 03/04/2025 (MT Newswires) -- Seven & i Holdings' founding family said it decided to pull its proposal to privatize the Japanese owner of the 7-Eleven convenience-store chain as it found it difficult to secure enough financing in a short time, The Wall Street Journal reported overnight Monday. Given that Seven & i is in a situation where...
Copyright 2023-2025 - www.financetom.com All Rights Reserved